Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 07, 2019

SELL
$83.25 - $102.12 $188,561 - $231,301
-2,265 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$90.66 - $116.63 $205,344 - $264,166
2,265 New
2,265 $226,000
Q2 2018

Aug 14, 2018

SELL
$71.53 - $95.75 $296,634 - $397,075
-4,147 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$60.72 - $74.41 $20,584 - $25,224
-339 Reduced 7.56%
4,147 $303,000
Q4 2017

Feb 27, 2019

SELL
$44.96 - $58.99 $2,607 - $3,421
-58 Reduced 1.28%
4,486 $264,000
Q4 2017

Nov 21, 2018

BUY
$44.96 - $58.99 $2,607 - $3,421
58 Added 1.29%
4,544 $264,000
Q4 2017

Feb 14, 2018

BUY
$44.96 - $58.99 $201,690 - $264,629
4,486
4,486 $260,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.58B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Ibex Investors LLC Portfolio

Follow Ibex Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ibex Investors LLC with notifications on news.